62 related articles for article (PubMed ID: 7288599)
1. The measurement of antagonist potency and the importance of selective inhibition of agonist uptake processes.
Kenakin TP; Beek D
J Pharmacol Exp Ther; 1981 Oct; 219(1):112-20. PubMed ID: 7288599
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of the pre- and postsynaptic alpha adrenoceptor antagonist potency of amitriptyline.
Leighton HJ
J Pharmacol Exp Ther; 1982 Feb; 220(2):299-304. PubMed ID: 6120225
[TBL] [Abstract][Full Text] [Related]
3. Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressions.
Kenakin TP
Mol Pharmacol; 1992 Apr; 41(4):699-707. PubMed ID: 1569922
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
[TBL] [Abstract][Full Text] [Related]
5. Self-cancellation of drug properties as a mode of organ selectivity: the antimuscarinic effects of ambenonium.
Kenakin TP; Beek D
J Pharmacol Exp Ther; 1985 Mar; 232(3):732-40. PubMed ID: 2857786
[TBL] [Abstract][Full Text] [Related]
6. Errors in the measurement of agonist potency-ratios produced by uptake processes: a general model applied to beta-adrenoceptor agonists.
Kenakin TP
Br J Pharmacol; 1980; 71(2):407-17. PubMed ID: 6110457
[TBL] [Abstract][Full Text] [Related]
7. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between AT(1) and AT(2) angiotensin receptors in rat anococcygeus smooth muscle.
de Godoy MA; de Oliveira AM
J Pharmacol Exp Ther; 2002 Oct; 303(1):333-9. PubMed ID: 12235268
[TBL] [Abstract][Full Text] [Related]
9. A new selective beta-adrenoceptor antagonist with carbanilate structure.
Sotníková R; Knezl V
Methods Find Exp Clin Pharmacol; 1993 Mar; 15(2):89-93. PubMed ID: 8098073
[TBL] [Abstract][Full Text] [Related]
10. Experimental and theoretical comparisons between the classical Schild analysis and a new alternative method to evaluate the pA2 of competitive antagonists.
Calderone V; Baragatti B; Breschi MC; Martinotti E
Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):477-87. PubMed ID: 10598787
[TBL] [Abstract][Full Text] [Related]
11. Kinetic studies of desensitization and resensitization of the relaxation response to beta-2 adrenoceptor agonists in isolated guinea pig trachea.
Wachsman DE; Kavaler JP; Sugár IP; Schachter EN; Gonsiorek W; Maayani S
J Pharmacol Exp Ther; 1997 Jan; 280(1):332-45. PubMed ID: 8996214
[TBL] [Abstract][Full Text] [Related]
12. The Schild regression in the process of receptor classification.
Kenakin TP
Can J Physiol Pharmacol; 1982 Mar; 60(3):249-65. PubMed ID: 7042056
[TBL] [Abstract][Full Text] [Related]
13. Studies on the mechanism of the inhibitory effect of desipramine (DMI) on vascular smooth muscle contraction.
Hrdina PD; Ling GM
J Pharmacol Exp Ther; 1970 Jun; 173(2):407-15. PubMed ID: 5434022
[No Abstract] [Full Text] [Related]
14. The effects on Schild regressions of antagonist removal from the receptor compartment by a saturable process.
Kenakin TP; Beek D
Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):103-8. PubMed ID: 3561525
[TBL] [Abstract][Full Text] [Related]
15. Antagonist inhibition curves and the measurement of dissociation constants.
Barlow RB; Bond SM; Bream E; Macfarlane L; McQueen DS
Br J Pharmacol; 1997 Jan; 120(1):13-8. PubMed ID: 9117087
[TBL] [Abstract][Full Text] [Related]
16. Effects of 138-355, a beta3-adrenoceptor selective agonist, on relaxation of the human detrusor muscle in vitro.
Yamanishi T; Yasuda K; Kitahara S; Nakai H; Yoshida K; Iizuka H
Neurourol Urodyn; 2006; 25(7):815-9. PubMed ID: 16998863
[TBL] [Abstract][Full Text] [Related]
17. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
Hopkins BJ; Hodgson WC; Sutherland SK
Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
[TBL] [Abstract][Full Text] [Related]
18. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
Germonpré PR; Joos GF; Pauwels RA
Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
[TBL] [Abstract][Full Text] [Related]
19. Differential attenuation of the responses to adenosine and methoxamine in isolated rabbit aorta.
Wiener HL; Thalody GP
J Pharmacol Exp Ther; 1993 Nov; 267(2):828-37. PubMed ID: 7902436
[TBL] [Abstract][Full Text] [Related]
20. Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties.
Patacchini R; Quartara L; Rovero P; Goso C; Maggi CA
J Pharmacol Exp Ther; 1993 Jan; 264(1):17-21. PubMed ID: 8380857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
